Largest endocrine gland. H-shaped. Lies at C5–T1, clasping upper trachea.
Hormones: T3 + T4 (metabolic rate, growth); Calcitonin (↓blood calcium; from parafollicular C cells; opposes PTH)
Special features: Only endocrine gland that is superficial, iodine-dependent, stores hormones extracellularly (as colloid), and is one of the most vascular organs.
| Structure | Dimensions |
|---|---|
| Each lateral lobe (conical) | 5×3×2 cm; apex to oblique line thyroid cartilage; base at 5th/6th tracheal ring |
| Isthmus | 1.25×1.25 cm; covers 2nd–4th tracheal rings |
| Total weight | ~25 g |
Pyramidal lobe — ~50%; projects upward from isthmus (usually left of midline); represents persistent lower thyroglossal duct; may be connected to hyoid by levator glandulae thyroideae
True capsule — thin fibrous; septa divide gland into lobules (20–40 follicles each)
False capsule (pretracheal fascia sheath) — from pretracheal layer of deep cervical fascia; loose sheath; posteriorly forms suspensory ligament of Berry (attaches posteromedial lobe to cricoid + 1st/2nd tracheal rings)
RLN passes posterior/just lateral to ligament of Berry before entering larynx — at risk during ligation near the ligament
Why thyroid moves on swallowing: False capsule derived from pretracheal fascia → attached to thyroid/cricoid/hyoid → these ascend on deglutition → gland moves upward = hallmark clinical sign
Space between capsules: Contains parathyroid glands (4), terminal thyroid artery branches, thyroid vein tributaries → surgical plane during thyroidectomy
Anterolateral (superficial) surface (superficial→deep): skin, superficial fascia (platysma), investing deep fascia, anterior jugular veins, sternohyoid, omohyoid, sternothyroid (directly applied; attachment to oblique line of thyroid cartilage limits upward expansion → goitres enlarge downward → retrosternal)
Medial surface: cricothyroid muscle + EBSLN (upper pole), thyroid cartilage, cricoid, trachea (1st–6th rings), cricothyroid joint, inferior constrictor, oesophagus (→ left side; left lobe goitre → dysphagia more readily), RLN in tracheo-oesophageal groove (most important surgical relation)
Posterolateral surface: common carotid artery (medial), IJV (lateral), vagus (between), sympathetic trunk, parathyroid glands
| Artery | Origin | Territory |
|---|---|---|
| Superior thyroid (paired) | First branch ECA | Upper pole + anterior surface |
| Inferior thyroid (paired) | Thyrocervical trunk (subclavian) | Lower pole + posterior + parathyroids |
| Thyroidea ima (unpaired, ~3–10%) | Brachiocephalic trunk (most common) / aortic arch | Isthmus from below |
Superior: ligate at upper pole capsule — protects EBSLN Inferior: ligate laterally — protects RLN and parathyroids Thyroidea ima: identify before tracheostomy/thyroidectomy — unexpected haemorrhage if cut unrecognised
RLN crossing inferior thyroid artery: may pass anterior, posterior, or between branches at posteromedial lobe
| Vein | Drains into |
|---|---|
| Superior thyroid | IJV (via facial vein or directly) |
| Middle thyroid | IJV directly (no accompanying artery) |
| Inferior thyroid | Left brachiocephalic vein (both sides) |
Middle thyroid vein — no accompanying artery; ligated first to mobilise lobe; tearing = brisk IJV haemorrhage Inferior thyroid veins form thyroid plexus in front of trachea — important in tracheostomy
1st echelon (Level VI/VII): Prelaryngeal (Delphian node — sentinel for thyroid Ca), pretracheal, paratracheal nodes
→ Deep cervical nodes (II–IV) → Superior mediastinal nodes (lower pole/isthmus)
Delphian node: enlarged hard midline prelaryngeal swelling = predicts thyroid malignancy
| Carcinoma type | Spread route |
|---|---|
| Papillary | Lymphatic (paratracheal, deep cervical; skip metastases) |
| Follicular | Haematogenous (bone, lung) |
| Medullary | Both |
| Anaplastic | Rapid local invasion + nodal |
Nerves at risk in surgery:
| Nerve | Effect of injury |
|---|---|
| RLN unilateral | Hoarseness, paramedian cord position |
| RLN bilateral | Stridor, respiratory distress, emergency tracheostomy |
| EBSLN | Loss of high-pitched voice, voice fatigue (Galli-Curci sign) |
| Sympathetic trunk | Horner’s syndrome (ptosis, miosis, anhidrosis, enophthalmos) |
Follicles — spherical sacs; wall = single layer of follicular cells (thyrocytes); lumen = colloid (PAS-positive thyroglobulin)
| State | Cell shape | Colloid |
|---|---|---|
| Active (↑TSH) | Columnar/cuboidal | Reduced; scalloped resorption lacunae |
| Resting (↓TSH) | Flat/squamous | Abundant, smooth, large follicle |
Parafollicular C cells — in follicle wall or interfollicular stroma, never lining lumen; large, pale polygonal; origin = neural crest → ultimobranchial body (4th pharyngeal pouch); secrete calcitonin; give rise to medullary carcinoma (calcitonin = tumour marker; RET mutation; MEN 2A + 2B)
| Source | Origin | Product |
|---|---|---|
| Median thyroid anlage | Foramen caecum (floor of pharynx, end of 3rd week) | Follicular cells → T3, T4 |
| Lateral thyroid anlage (ultimobranchial body) | 4th pharyngeal pouch + neural crest | Parafollicular C cells → calcitonin |
Descent: foramen caecum → through/past hyoid → final position C5–T1; thyroglossal duct obliterates by 8th–10th week; foramen caecum = only normal remnant
Duct passes through body of hyoid → Sistrunk’s operation excises central hyoid to prevent cyst recurrence
Congenital anomalies:
| Anomaly | Key feature | Treatment |
|---|---|---|
| Thyroglossal cyst (most common) | Midline; moves on swallowing AND tongue protrusion; most common at subhyoid (60%) | Sistrunk’s operation |
| Thyroglossal fistula | Midline; mucoid discharge | Sistrunk’s operation |
| Lingual thyroid | Base of tongue; most common ectopic site; may be only functioning thyroid | Scan before excision |
| Agenesis | Congenital hypothyroidism (cretinism); detected by neonatal TSH screen (Guthrie test) | Lifelong thyroxine |
Goitre — any thyroid enlargement regardless of cause/function
Thyroid carcinoma:
| Type | Frequency | Origin | Spread | Prognosis | Marker |
|---|---|---|---|---|---|
| Papillary | ~60% | Follicular cells | Lymphatic; skip metastases; radiation-associated | Excellent (>90% 20-yr) | — |
| Follicular | ~25% | Follicular cells | Haematogenous (bone, lung); FNAC cannot distinguish from adenoma | Good | — |
| Medullary | ~5–10% | C cells; RET mutation | Lymphatic + haematogenous | Intermediate | Calcitonin, CEA |
| Anaplastic | ~5% | Follicular cells | Rapid local + nodal | Very poor | — |
MEN associations: MEN 2A = medullary Ca + phaeochromocytoma + hyperparathyroidism; MEN 2B = medullary Ca + phaeochromocytoma + mucosal neuromas
Thyroid surgery steps (Kocher’s incision):
Hypoparathyroidism post-thyroidectomy — most common complication of total thyroidectomy
Thyrotoxicosis:
| Cause | Mechanism |
|---|---|
| Graves’ disease | TSH-R antibodies (thyroid-stimulating immunoglobulins); diffuse toxic goitre; autoimmune |
| Toxic multinodular goitre (Plummer’s) | Autonomous hypersecretion from multiple nodules |
| Toxic adenoma | Single autonomously functioning (hot) nodule |
Pretibial myxoedema — raised non-pitting skin thickening over shins = pathognomonic for Graves’
The thyroid gland is the largest endocrine gland in the body, lying in the lower front and sides of the neck opposite vertebrae C5, C6, C7 and T1, clasping the upper trachea. It is H-shaped, consisting of two lateral lobes connected by an isthmus.
Hormones secreted:
Special features:
Each lobe is conical (pyramidal) in shape:
| Structure | Dimensions |
|---|---|
| Each lateral lobe | 5 cm × 3 cm × 2 cm |
| Isthmus | 1.25 cm × 1.25 cm |
| Total weight | ~25 g |
The gland is larger in females; increases further during menstruation and pregnancy.
The loose areolar tissue between the capsules contains:
This space is the surgical plane developed during thyroidectomy to preserve parathyroids and recurrent laryngeal nerves.
The false capsule is derived from pretracheal fascia, which is attached superiorly to the thyroid cartilage, cricoid cartilage and hyoid bone. These structures ascend during deglutition, carrying the gland upward. All thyroid swellings therefore move upward on swallowing — the hallmark clinical sign.
From superficial to deep:
| Structure | Notes |
|---|---|
| Cricothyroid muscle (upper pole) | Crossed by EBSLN — at risk during superior thyroid artery ligation |
| Thyroid cartilage | Upper half of lobe |
| Cricoid cartilage | At isthmus level |
| Trachea | 1st–6th rings |
| Cricothyroid joint and muscle | — |
| Pharynx — inferior constrictor | Posteromedially |
| Oesophagus | Tends to the left — left lobe goitre causes dysphagia more readily |
| Recurrent laryngeal nerve | In the tracheo-oesophageal groove — most important surgical relation |
| Border / Surface | Relation |
|---|---|
| Anterior | Skin, fascia, anterior jugular veins, sternohyoid, sternothyroid |
| Posterior | 2nd–4th tracheal rings |
| Upper border | Anastomotic vessel between superior thyroid arteries; sometimes thyroidea ima artery |
| Lower border | Inferior thyroid veins; thymic tissue; thyroidea ima artery (if present) |
| Side | Course |
|---|---|
| Right RLN | Hooks under right subclavian artery → ascends in right tracheo-oesophageal groove |
| Left RLN | Hooks under aortic arch (posterior to ligamentum arteriosum) → ascends in left tracheo-oesophageal groove |
The RLN crosses the inferior thyroid artery at the posteromedial lobe — it may pass anterior, posterior or between branches. Ligate the inferior thyroid artery laterally, never at the gland.
The thyroid gland is one of the most vascular organs in the body.
| Artery | Origin | Territory |
|---|---|---|
| Superior thyroid artery (paired) | First branch of external carotid artery | Upper pole + anterior surface |
| Inferior thyroid artery (paired) | Thyrocervical trunk (1st part subclavian artery) | Lower pole + posterior surface + parathyroids |
| Thyroidea ima artery (unpaired, ~3–10%) | Brachiocephalic trunk (most common) / aortic arch | Isthmus from below |
| Vein | Drains From | Drains Into |
|---|---|---|
| Superior thyroid vein | Upper pole | Internal jugular vein (via facial vein or directly) |
| Middle thyroid vein | Middle of lateral lobe | Internal jugular vein directly |
| Inferior thyroid veins | Lower pole + isthmus | Left brachiocephalic vein (both sides typically) |
Middle thyroid vein has no accompanying artery — ligated first during thyroidectomy to mobilise the lobe. Tearing it before ligation causes brisk haemorrhage from the internal jugular vein.
Inferior thyroid veins form the thyroid plexus in front of the trachea — important in tracheostomy.
| Node | Location | Significance |
|---|---|---|
| Prelaryngeal node (Delphian node) | Anterior to cricothyroid ligament | Enlarged → sentinel for thyroid carcinoma |
| Pretracheal nodes | Anterior to trachea | — |
| Paratracheal nodes | Tracheo-oesophageal groove | Alongside RLN |
→ Deep cervical nodes (levels II–IV) → Superior mediastinal nodes (lower pole and isthmus)
Delphian node: An enlarged, hard, midline prelaryngeal swelling predicts (foretells) thyroid malignancy — named after the Oracle at Delphi.
| Type | Route |
|---|---|
| Papillary | Predominantly lymphatic — paratracheal and deep cervical nodes; skip metastases |
| Follicular | Predominantly haematogenous — bone and lung |
| Medullary | Both lymphatic and haematogenous |
| Anaplastic | Rapid extensive local invasion and nodal spread |
The thyroid gland receives only vasomotor (sympathetic) fibres — no secretomotor innervation. Hormone secretion is regulated entirely by TSH from the anterior pituitary.
Sympathetic: Superior, middle and inferior cervical ganglia → travel along superior and inferior thyroid arteries as perivascular plexuses → vasomotor function.
Parasympathetic: Vagus (minor contribution via laryngeal branches — vasodilatory).
| Nerve | Function | Effect of Injury |
|---|---|---|
| Recurrent laryngeal nerve | Motor to all intrinsic laryngeal muscles except cricothyroid; sensory to subglottis | Unilateral → hoarseness, paramedian cord; Bilateral → stridor, respiratory distress, tracheostomy |
| External branch of SLN (EBSLN) | Motor to cricothyroid only — tenses vocal cords; high-pitched phonation | Loss of high-pitched voice; voice fatigue (Amelita Galli-Curci sign) |
| Sympathetic trunk | Vasomotor | Horner’s syndrome — ptosis, miosis, anhidrosis, enophthalmos |
The thyroid is the only endocrine gland that stores its secretory product extracellularly — as colloid within follicles.
| State | Cell Shape | Colloid |
|---|---|---|
| Active / stimulated (high TSH) | Columnar / cuboidal | Reduced; scalloped resorption lacunae at margins |
| Resting / inactive (low TSH) | Flat / squamous | Abundant; smooth margins; large follicle |
Function of follicular cells: Synthesise thyroglobulin → iodinate in colloid → reabsorb by endocytosis → cleave with proteolytic enzymes → secrete T3 and T4 into bloodstream.
| Feature | Detail |
|---|---|
| Location | In follicle wall or interfollicular stroma — never lining the lumen |
| Origin | Neural crest → ultimobranchial body (4th pharyngeal pouch) |
| Appearance | Large, pale (clear), polygonal cells |
| Secretion | Calcitonin — lowers blood calcium |
| Stain | Argyrophilic; calcitonin immunohistochemistry positive |
| Clinical | Give rise to medullary carcinoma (calcitonin = tumour marker; RET mutation; MEN 2A and 2B) |
| Feature | Active Gland | Resting Gland |
|---|---|---|
| Cells | Tall columnar | Flat/squamous |
| Follicle lumen | Small | Large |
| Colloid | Reduced; scalloped | Abundant; smooth |
| Appearance (Graves’) | Columnar cells, papillary infoldings, scalloped colloid | — |
| Source | Embryological Origin | Product |
|---|---|---|
| Median thyroid anlage (thyroid diverticulum) | Floor of pharynx at foramen caecum (junction of anterior 2/3 and posterior 1/3 of tongue) — endodermal | Follicular cells → T3, T4 |
| Lateral thyroid anlage (ultimobranchial body) | 4th pharyngeal pouch + neural crest | Parafollicular C cells → calcitonin |
| Week | Event |
|---|---|
| End of 3rd week (day 24) | Thyroid diverticulum appears at foramen caecum as a hollow midline outgrowth |
| 4th–7th week | Descends in midline; passes anterior to / through the hyoid bone; reaches final position at C5–T1 level |
| 8th–10th week | Thyroglossal duct obliterates; foramen caecum persists as only normal remnant |
| 10th week | Follicles begin to form; colloid appears |
| 12th week | Gland functional; T4 detectable in fetal serum |
The thyroglossal duct passes through the body of the hyoid bone — explaining why Sistrunk’s operation excises the central portion of the hyoid to prevent cyst recurrence.
| Anomaly | Features | Key Point | Treatment |
|---|---|---|---|
| Thyroglossal cyst (most common) | Midline swelling; moves up on swallowing AND on tongue protrusion | Most common at subhyoid (60%) | Sistrunk’s operation (cyst + central hyoid body + track to foramen caecum) |
| Thyroglossal fistula | Midline opening; mucoid discharge | From infected/ruptured/incompletely excised cyst | Sistrunk’s operation |
| Lingual thyroid | Base of tongue; midline mass; moves on swallowing and tongue protrusion | Most common ectopic site; may be only functioning thyroid | Thyroid scan before excision |
| Ectopic thyroid | Anywhere along path of descent (sublingual, retrosternal) | Undergoes all pathological changes | — |
| Agenesis / dysgenesis | Congenital hypothyroidism (cretinism) | Detected by neonatal TSH screen (Guthrie test) | Lifelong thyroxine |
Any enlargement of the thyroid gland regardless of cause or functional status.
| Type | Examples |
|---|---|
| Simple non-toxic | Iodine deficiency (endemic), puberty, pregnancy |
| Toxic | Graves’ disease, toxic multinodular goitre, toxic adenoma |
| Non-toxic nodular | Colloid cyst, follicular adenoma, multinodular goitre |
| Malignant | Carcinoma |
Iodine-deficiency goitre (endemic): Low iodine → low T3/T4 → ↑TSH → diffuse thyroid hyperplasia. Prevention: iodised salt.
| Type | Frequency | Origin | Spread | Prognosis | Marker |
|---|---|---|---|---|---|
| Papillary | ~60% | Follicular cells | Lymphatic (early, extensive); skip metastases; radiation-associated | Excellent (20-yr survival >90%) | — |
| Follicular | ~25% | Follicular cells | Haematogenous — bone, lung; cannot be distinguished from adenoma on FNAC | Good | — |
| Medullary | ~5–10% | Parafollicular C cells; RET mutation | Lymphatic + haematogenous | Intermediate | Calcitonin, CEA |
| Anaplastic | ~5% | Follicular cells | Rapid local + nodal | Very poor | — |
| Lymphoma | Rare | B lymphocytes | — | Variable | — |
Medullary carcinoma associations:
| Nerve Injured | Cause | Effect |
|---|---|---|
| RLN unilateral | Near inferior thyroid artery / ligament of Berry | Hoarseness; paramedian cord |
| RLN bilateral | Total thyroidectomy without nerve identification | Stridor; respiratory distress; emergency tracheostomy |
| EBSLN | Superior thyroid artery ligation proximally | Loss of high-pitched voice; cricothyroid paralysis |
| Sympathetic trunk | Extensive dissection | Horner’s syndrome |
Most common complication of total thyroidectomy — from inadvertent removal or devascularisation of parathyroids.
| Cause | Mechanism |
|---|---|
| Graves’ disease | TSH receptor antibodies (thyroid-stimulating immunoglobulins); diffuse toxic goitre; autoimmune |
| Toxic multinodular goitre (Plummer’s) | Autonomous hypersecretion from multiple nodules |
| Toxic adenoma | Single autonomously functioning (hot) nodule |
Features: Weight loss despite increased appetite, heat intolerance, sweating, palpitations, tremor, anxiety, diarrhoea, goitre, exophthalmos (Graves’ only), pretibial myxoedema (Graves’ — pathognomonic; raised non-pitting skin thickening over shins).
Treatment: Antithyroid drugs (carbimazole/propylthiouracil), radioiodine (¹³¹I), surgery.
| Investigation | Use |
|---|---|
| TSH | Best initial screen — low = hyperthyroidism; high = hypothyroidism |
| Free T3, Free T4 | Confirm functional status |
| Thyroid antibodies (TPO, TSH-R Ab) | Graves’ disease, Hashimoto’s thyroiditis |
| Ultrasound | Structure, nodule characterisation, guided FNAC |
| FNAC | First-line for nodules; cannot diagnose follicular carcinoma (needs histology) |
| Radioisotope scan (⁹⁹ᵐTc / ¹²³I) | Hot nodule (toxic), cold nodule (higher malignancy risk), ectopic thyroid |
| Serum calcitonin | Medullary carcinoma; MEN2 screening |
| CEA | Medullary carcinoma monitoring |
Diagram content will be added later.
Personal revision notes, mnemonics and reminders.
